Shuntaro Sakai

Rivaroxaban attenuates cardiac hypertrophy by inhibiting protease-activated receptor-2 signaling in renin-overexpressing hypertensive mice

H. Tomita, K. Okumura, T. Osanai, 2021, Hypertension Research.

Prognostic Impact of Diabetes Mellitus on Clinical Outcomes in Lean Patients With Acute Myocardial Infarction

H. Tomita, T. Yokota, H. Yokoyama, 2022, In Vivo.

Characterization of the PRAETORIAN score in Japanese patients undergoing subcutaneous implantable cardioverter-defibrillator implantation.

M. Kimura, S. Sasaki, Taihei Itoh, 2022, Journal of cardiology.